TECHNOLOGY – Phoenix PharamLabs
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Hot topics in opioid pharmacology: mixed and biased opioids - British Journal of Anaesthesia
N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor Agonists | Scientific Reports
Oxycodone - St Elizabeth Hospice
Oxycodone - Wikipedia
Opioids in cancer: The κ‑opioid receptor (Review)
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids | PLOS ONE
Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric site | eLife
Frontiers | BOLD Imaging in Awake Wild-Type and Mu-Opioid Receptor Knock-Out Mice Reveals On-Target Activation Maps in Response to Oxycodone
Oxycodone Pathway, Pharmacokinetics
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Kappa Receptors – Opioid Peptides
Pharmaceutics | Free Full-Text | Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism
CODEINE AND OXYCODONE - Molecule of the Month - HTML-only version
κ-opioid receptor - Wikipedia
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Oxycodone-Mediated Activation of the Mu Opioid Receptor Reduces Whole Brain Functional Connectivity in Mice | ACS Pharmacology & Translational Science
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
:no_upscale()/cdn.vox-cdn.com/uploads/chorus_image/image/58663933/GettyImages-563590877.0.jpg "OxyContin maker Purdue Pharma to stop promoting opioids to doctors - Vox")
OxyContin maker Purdue Pharma to stop promoting opioids to doctors - Vox
Damage From OxyContin Continues to Be Revealed - The New York Times
Antioxidants | Free Full-Text | Opioids and Vitamin C: Known Interactions and Potential for Redox-Signaling Crosstalk
Oxycodone - Wikipedia
Does the pharmacology of oxycodone justify its increasing use as an analgesic?: Trends in Pharmacological Sciences
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
